FDA approves first human trial for Paradromics' brain-computer interface that could restore speech for paralyzed patients ...

It will be a holiday season to remember for one Edmond family. Their 11-month-old daughter experienced the gift of sound for the first time when her cochlear implant was ...

Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

GURUGRAM-In a nation obsessed with ranks, cut-offs, and entrance examinations, where adolescence often feels like a relentless race toward the hallowed portals of the IITs, there occasionally emerges ...

The ability of these devices to access aspects of a person’s innermost life, including preconscious thought, raises the ...

Many children are diagnosed with otitis media with effusion, commonly known as “glue ear,” a condition where fluid collects ...

US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, ...

Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.

The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.

Neural Speech Inc. aims to provide a link to the outside world for people who are unable to communicate, Philip Kennedy, ...

Abstract: An electrolarynx, a widely used assistive device for voice restoration for individuals with laryngeal impairments, often suffers from mechanical buzz and poor intelligibility, limiting its ...